Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure
about
17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol productionMalignant transformation of rat kidney induced by environmental substances and estrogenChronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells.Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsivenessMorphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptorsInfluence of endogenous reproductive hormones on F2-isoprostane levels in premenopausal women: the BioCycle Study.Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesisAntioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancermiR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.NO to breast: when, why and why not?Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherolInduction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI ratsDietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγDietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancerSuperoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.Spatholobus suberectus Column Extract Inhibits Estrogen Receptor Positive Breast Cancer via Suppressing ER MAPK PI3K/AKT PathwayTamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.Estrogen Drives Cellular Transformation and Mutagenesis in Cells Expressing the Breast Cancer-Associated R438W DNA Polymerase Lambda Protein.The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.Antioxidant activities of novel resveratrol analogs in breast cancer.Modulatory Effect of Fermented Papaya Extracts on Mammary Gland Hyperplasia Induced by Estrogen and Progestin in Female Rats.Markers of lipid peroxidation and α-tocopherol levels in the blood and neoplastic tissue of dogs with malignant mammary gland tumors.
P2860
Q27659972-E7900BE5-5790-4B78-9275-D8E783962812Q28385903-0D281504-21C9-4C71-85D4-062570AB9A4EQ31149230-4496CB44-830A-4189-9DDE-97DC46084E48Q33554013-69853A89-7F74-4FC1-A5E0-2759F48F948CQ33711108-710CC9BA-D05C-448A-9699-DC7A3CF792A9Q33889022-6A76008F-FB64-4AAB-A8FA-BF7EC7DE3D19Q34010001-8D5891DB-F757-4AF4-945E-9C02616BD741Q34038020-C20EBD71-17F7-42A6-A34E-D24217A6EC8FQ34148850-7A818E86-86B2-4B16-82E5-0D2C2A2348DAQ34179421-8757E3A8-5F21-4A89-8493-37F48C2C7934Q34332592-71B140F6-3DB9-474E-8BA9-DD0F9BE7607AQ34641803-54816088-17C0-4102-84E2-2E6CA11A4B3AQ34734464-5500A066-9227-4B8C-8C48-387F28F65CD2Q35562532-C7945370-F794-4467-A7AB-1297D9658D38Q35563549-97F1EAA8-60EC-4D9C-A976-FF6BA03EADC9Q35671133-2FFC9504-8427-4DB4-91B9-E42FAE877039Q35747349-96F9903C-4E41-4B43-93B6-22C7811776AAQ35822954-4C456D92-072D-4C89-8770-0B3EBEA8288CQ36029637-491C8C6D-87BB-48F9-B115-C5D701352380Q36031004-1B149BAE-3E45-46BD-8F5C-824D01F4E7F3Q36134671-0C87867B-2379-4222-B71F-6ED3CF64F06AQ36435800-9AA8823B-E20F-4ED1-BE53-9BF28E3D0285Q36814001-BE40DA50-946B-466C-83ED-83FC8E623FA9Q37246680-2601357E-D3EA-4C37-9F13-02CE9CD61D99Q37554145-2ECFF295-8DDD-483E-AFB7-2B9BFEE828DAQ37588360-530D9665-1AA7-4EFF-B15B-4182AB13B5C8Q38733937-3A1DD5A1-F28B-4CD9-A89C-9FEBF00E7F05Q39344606-3AF5089B-0A2B-4D1E-926D-7A35A0D62CBDQ46299051-71A0BEB5-74B5-460D-9770-86AEC070C23AQ47550231-98DB30DF-1D58-4FFA-93EB-D79B7EDE5332Q51219092-A1D10A36-91DA-466A-9A11-935E2510CED0
P2860
Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Estrogen-induced breast cancer ...... function of estrogen exposure
@en
type
label
Estrogen-induced breast cancer ...... function of estrogen exposure
@en
prefLabel
Estrogen-induced breast cancer ...... function of estrogen exposure
@en
P2093
P2860
P1476
Estrogen-induced breast cancer ...... function of estrogen exposure
@en
P2093
Ashima Bhan
Bhupendra Singh
Fabrizio Remotti
Hari K Bhat
Mahmoud El-Tamer
Sarah M Mense
P2860
P356
10.1016/J.TAAP.2008.06.007
P577
2008-07-01T00:00:00Z